18F-PFPMD PET/CT imaging of NSCLC and CRC patients. (IMAGE)

Society of Nuclear Medicine and Molecular Imaging

18F-PFPMD PET/CT imaging of NSCLC and CRC patients.

Caption

Figure 5. 18F-PFPMD PET/CT imaging of NSCLC and CRC patients. (A) Representative 18F-PFPMD PET/CT images of non-KRASG12C and KRASG12C tumors in NSCLC and CRC patients, respectively. (B) SUVmax of 18F-PFPMD and 18F-FDG in non-KRASG12C and KRASG12C tumors, respectively (KRASG12C, n = 6; non-KRASG12C, n = 8). (C) 18F-PFPMD SUVmax of non-KRASG12C tumors, KRASG12C tumors, and healthy tissue in NSCLC patients, CRC patients, and healthy volunteers, respectively (NSCLC: KRASG12C, n = 3; non-KRASG12C, n = 5; healthy, n = 5) (CRC: KRASG12C, n = 3; non-KRASG12C, n = 3; healthy, n = 5). ns = not statistically significant.

Credit

Image created by X Li and J Ye, et al, Xijing Hospital, Xi’an, China.

Usage Restrictions

Please give appropriate credit.

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.